Plant Comparison
Andrographis vs Borage
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Andrographis and Borage: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), cold & flu, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Andrographis | Borage | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Andrographis |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Cold & flu | 8/10 | 1/10 | Stronger for Andrographis |
| Immune support | 5/10 | 1/10 | Stronger for Andrographis |
| Inflammation (general) | 5/10 | 1/10 | Stronger for Andrographis |
| Skin irritation | 5/10 | 1/10 | Stronger for Andrographis |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Borage seed oil has one of the highest known GLA contents of any plant oil (typically 20-26%), the basis of its anti-inflammatory reputation.
Unsaturated pyrrolizidine alkaloids present in the whole herb are hepatotoxic and genotoxic on cumulative exposure, limiting internal whole-herb use; the refined seed oil is largely free of them.
Contribute to the plant's traditional demulcent and astringent properties.
Pharmacological Actions
Andrographolide, the principal diterpene lactone of Andrographis paniculata, suppresses proliferation and induces apoptosis across breast, lung, colon, cervical, hepatic and haematological cancers via NF-kappaB and PI3K/Akt inhibition (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Andrographolide (from Andrographis paniculata) acts as a chemopreventive and antitumour agent against breast, lung, colorectal, cervical, prostate and hepatocellular cancers and leukaemia, inducing apoptosis and inhibiting NF-kappaB and PI3K/AKT signalling (preclinical).
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
Immunostimulant / immune support
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from immunomodulator action
inferred from digestive action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid in pregnancy and when trying to conceive: high doses have shown reproductive toxicity in animals and the herb has a traditional reputation as an abortifacient.
High doses have caused nephrotoxicity and reproductive toxicity in studies; use standardized products at recommended doses and avoid prolonged high-dose use.
Pyrrolizidine alkaloids (PAs): Many Boraginaceae can produce PAs; unsaturated PAs are hepatotoxic and genotoxic (risk increases with cumulative exposure). Borage as food/tea: PA presence in borage consumed as herb/tea has been specifically studied; EU has set PA maximum levels for certain foods including borage (context for why sourcing/limits matter). Pregnancy/breastfeeding: avoid internal use of borage herb products due to PA-related concerns and risk uncertainty. Liver disease / long-term use: avoid (PA risk + cumulative exposure logic). Seed oil vs herb: refined/quality-controlled seed oil is generally the preferred form when borage is used medicinally, because the main target compound is GLA; however, product quality and contamination control still matter. Drug interactions (caution): GLA oils have been discussed with anticoagulants (bleeding risk caution is better established for evening primrose oil; borage oil is often grouped in the same “GLA oil” category). Use caution if on anticoagulants/antiplatelets.
Duke (2002) rates borage as a single-plus herb (+) with predominantly folklore-level evidence. Borage seed oil is rich in gamma-linolenic acid (GLA) and has been used for inflammatory conditions such as arthritis and PMS, and for cardiovascular support; typical dose is one 300 mg softgel containing 24% GLA or 2-4 ml liquid leaf extract. Commission E does not approve borage for any indication, and the herb contains hepatotoxic and carcinogenic pyrrolizidine alkaloids, making long-term use inadvisable (Duke, 2002).
External Ids
Botanical Description
Erect, branching annual herb with a slender, quadrangular (square-sectioned), dark green stem. The leaves are opposite, lance-shaped and glabrous, with a short stalk. Small, two-lipped, white flowers with purple-pink markings are borne in loose, spreading axillary and terminal racemes. The whole plant, and especially the leaves, is intensely and characteristically bitter.[11]
Robust, bristly annual herb with hollow, branching stems covered in coarse, stiff hairs. The leaves are large, oval and wrinkled, also coarsely hairy, and smell of cucumber when crushed. The flowers are strikingly bright blue, star-shaped with five pointed petals and a prominent black central cone of anthers, borne in nodding clusters.[1]
Habitat
Native to India and Sri Lanka and widely distributed through South and Southeast Asia, growing wild in plains, hillsides, roadsides and cultivated fields; also grown commercially as a medicinal crop.[11]
Grows readily on disturbed, nutrient-rich ground, gardens, waste places and field margins; native to the Mediterranean region and widely naturalised and cultivated across Europe and elsewhere as a culinary and oil-seed crop.[1]
Harvesting
The aerial parts (leaves and tender stems) are cut just before or at the onset of flowering, when andrographolide content is typically highest, and dried in shade to preserve the bitter diterpenoid lactones.[11]
Leaves and flowers are picked fresh through the growing season, at their best just as the flowers open; the seed is collected in late summer once the seed heads have dried, pressed for its gamma-linolenic-acid-rich oil.[1]
Traditional Uses
Andrographis, the 'king of bitters', is a cornerstone bitter tonic of Ayurvedic and traditional Chinese medicine (Chuan xin lian), used for fevers, colds, sore throat, infections and liver complaints. This traditional reputation for treating the common cold and upper respiratory infections is now supported by clinical trials of standardised extracts.[10, 12]
Borage has a long folk reputation, reflected in the old saying 'borage for courage', as a mood-lifting, cooling herb for feverish colds and respiratory complaints, and as a digestive and anti-inflammatory remedy; the fresh leaves and flowers have also been used culinarily. Modern use is centred on the seed oil, rich in gamma-linolenic acid (GLA), for inflammatory and skin conditions.[1]
Preparations
Dried aerial parts infused or lightly decocted in hot water as a very bitter traditional fever and cold remedy.
Dosage
Clinical trials for upper respiratory infection commonly use extracts standardised to around 60-120 mg andrographolide daily, in divided doses, for up to 5-7 days. Educational reference only, not a prescription.
The WHO monograph on Herba Andrographidis gives, by indication - for the common cold, 1.5-3.0 g of the powdered crude drug three times daily, after meals and at bedtime; for pyrexia, a decoction from 3 g of the crude drug twice daily; for diarrhoea, a decoction from 3-9 g as a single dose as needed, or two 500 mg tablets four times daily. Note that the EMA HMPC assessed this herb and issued a public statement rather than a monograph, so there is no EU posology. Educational reference only, not a prescription.
A phase-two randomised placebo-controlled trial in moderate persistent asthma used Borago officinalis extract at 5 mL three times daily for one month. Because of pyrrolizidine alkaloid content, whole-herb (leaf/flower) preparations should only be used short-term and from PA-controlled sources; avoid in pregnancy, breastfeeding and liver disease. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Okonogi, R. and others (2023) 'Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial', Drug Discoveries & Therapeutics, 17(5), pp. 315-321. doi:10.5582/ddt.2023.01053 Randomized trial
https://doi.org/10.5582/ddt.2023.01053 - Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R.B. and others (2018) 'Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide', Critical Reviews in Food Science and Nutrition, 61(10), pp. 1635-1652. doi:10.1080/10408398.2018.1501657 Meta-analysis / review
https://doi.org/10.1080/10408398.2018.1501657 - Worakunphanich, W. and others (2021) 'Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability', European Journal of Drug Metabolism and Pharmacokinetics, 46(5), pp. 565-581. doi:10.1007/s13318-021-00736-7 Meta-analysis / review
https://doi.org/10.1007/s13318-021-00736-7 - Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thakkinstian, A. and Chaikledkaew, U (2021) 'Safety of Andrographis paniculata: A systematic review and meta-analysis', Pharmacoepidemiology and Drug Safety, 30(6), pp. 727-739. doi:10.1002/pds.5190 Meta-analysis / review
https://doi.org/10.1002/pds.5190 - Kumar, S., Singh, B. and Bajpai, V (2021) 'Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents', Journal of Ethnopharmacology, 274, pp. 113954. doi:10.1016/j.jep.2021.113954 Meta-analysis / review
https://doi.org/10.1016/j.jep.2021.113954 - Barbosa, F.L. and others (2021) 'Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy', Life, 11(4), pp. 348. doi:10.3390/life11040348 Meta-analysis / review
https://doi.org/10.3390/life11040348 - Singh, P. and others (2022) 'Andrographis paniculata mitigates first-line anti-tubercular drugs-induced nephrotoxicity in Wistar rats', Biomarkers, 27(4), pp. 385-394. doi:10.1080/1354750X.2022.2043444 Preclinical
https://doi.org/10.1080/1354750X.2022.2043444 - Coon, J.T. and Ernst, E (2004) 'Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials', Journal of Clinical Pharmacy and Therapeutics, 29(1), pp. 37-45. doi:10.1046/j.1365-2710.2003.00534.x Meta-analysis / review
https://doi.org/10.1046/j.1365-2710.2003.00534.x - Rondee, N. and others (2023) 'The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases', Nutrients, 15(15), pp. 3428. doi:10.3390/nu15153428 Meta-analysis / review
https://doi.org/10.3390/nu15153428 - Zeng, B., Wei, A., Zhou, Q., Yuan, M., Lei, K., Liu, Y., Song, J., Guo, L. and Ye, Q (2021) 'Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches', Phytotherapy Research. doi:10.1002/ptr.7324 Randomized trial
https://doi.org/10.1002/ptr.7324 - Gonde, D.P., Bhole, B.K. and Kakad, K.S (2023) 'Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology', Annales Pharmaceutiques Francaises. doi:10.1016/j.pharma.2023.10.001 Preclinical
https://doi.org/10.1016/j.pharma.2023.10.001 - Hu, X.Y., Wu, R.H., Logue, M., Blondel, C., Lai, L.Y.W., Stuart, B., Flower, A., Fei, Y.T., Moore, M., Shepherd, J., Liu, J.P. and Lewith, G (2017) 'Andrographis paniculata (Chuan Xin Lian) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis', PLoS ONE. doi:10.1371/journal.pone.0181780 Meta-analysis / review
https://doi.org/10.1371/journal.pone.0181780 - World Health Organization (2002) 'Herba Andrographidis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Tundis, R. and Patra, J.K. and Bonesi, M. and Das, S. and Nath, R. and Das Talukdar, A. and Das, G. and Loizzo, M.R (2023) 'Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide', Plants, 12(10), pp. 1969. doi:10.3390/plants12101969 Preclinical
https://doi.org/10.3390/plants12101969 - Mishra, S.K. and Tripathi, S. and Shukla, A. and Oh, S.H. and Kim, H.M (2015) 'Andrographolide and analogues in cancer prevention', Frontiers in Bioscience (Elite Edition), 7(2), pp. 255-266. doi:10.2741/E732 Preclinical
https://doi.org/10.2741/E732 - Paul, S. and Roy, D. and Pati, S. and Sa, G (2021) 'The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer', Frontiers in Pharmacology, 12, pp. 731492. doi:10.3389/fphar.2021.731492 Preclinical
https://doi.org/10.3389/fphar.2021.731492 - Memorial Sloan Kettering Cancer Center (n.d.) 'Andrographis (About Herbs)'. Available at: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis Traditional / reference
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis
- Slama, M., Slougui, N., Benaissa, A., Nekkaa, A. et al (2024) 'Borago officinalis L.: A Review on Extraction, Phytochemical, and Pharmacological Activities', Chemistry & Biodiversity, 21(5), pp. e202301822. doi:10.1002/cbdv.202301822 Traditional / reference
https://doi.org/10.1002/cbdv.202301822 - Michalak, M., Zagórska-Dziok, M., Klimek-Szczykutowicz, M. and Szopa, A (2023) 'Phenolic Profile and Comparison of the Antioxidant, Anti-Ageing, Anti-Inflammatory, and Protective Activities of Borago officinalis Extracts on Skin Cells', Molecules, 28(2), pp. 868. doi:10.3390/molecules28020868 Preclinical
https://doi.org/10.3390/molecules28020868 - Ghasemian, M., Owlia, S. and Owlia, M.B (2016) 'Review of Anti-Inflammatory Herbal Medicines', Advances in Pharmacological Sciences, 2016, pp. 9130979. doi:10.1155/2016/9130979 Traditional / reference
https://doi.org/10.1155/2016/9130979 - Di Cerbo, A., Carnevale, G., Avallone, R., Zavatti, M. and Corsi, L (2020) 'Protective Effects of Borago officinalis (Borago) on Cold Restraint Stress-Induced Gastric Ulcers in Rats: A Pilot Study', Frontiers in Veterinary Science, 7, pp. 427. doi:10.3389/fvets.2020.00427 Preclinical
https://doi.org/10.3389/fvets.2020.00427 - Seo, S.A., Park, B., Hwang, E., Park, S. and Yi, T (2018) 'Borago officinalis L. attenuates UVB-induced skin photodamage via regulation of AP-1 and Nrf2/ARE pathway in normal human dermal fibroblasts and promotion of collagen synthesis in hairless mice', Experimental Gerontology, 107, pp. 178-186. doi:10.1016/j.exger.2018.02.017 Preclinical
https://doi.org/10.1016/j.exger.2018.02.017 - Mirsadraee, M., Khashkhashi Moghaddam, S., Saeedi, P. and Ghaffari, S (2016) 'Effect of Borago Officinalis Extract on Moderate Persistent Asthma: A Phase two Randomized, Double Blind, Placebo-Controlled Clinical Trial', Tanaffos, 15(3), pp. 168-174. doi:10.1183/13993003.congress-2016.pa4116 Randomized trial
https://doi.org/10.1183/13993003.congress-2016.pa4116 - Lozano-Baena, M., Tasset, I., Munoz-Serrano, A., Alonso-Moraga, A. and de Haro-Bailon, A (2016) 'Cancer Prevention and Health Benefices of Traditionally Consumed Borago officinalis Plants', Nutrients, 8(1), pp. 48. doi:10.3390/nu8010048 Preclinical
https://doi.org/10.3390/nu8010048 - Rodriguez-Magana, M.P., Cordero-Perez, P., Rivas-Morales, C., Oranday-Cardenas, M.A., Moreno-Pena, D.P., Garcia-Hernandez, D.G. and Leos-Rivas, C (2019) 'Hypoglycemic Activity of Tilia americana, Borago officinalis, Chenopodium nuttalliae, and Piper sanctum on Wistar Rats', Journal of Diabetes Research, 2019, pp. 7836820. doi:10.1155/2019/7836820 Preclinical
https://doi.org/10.1155/2019/7836820 - Navarro-Herrera, D., Aranaz, P., Eder-Azanza, L., Zabala, M., Romo-Hualde, A., Hurtado, C., Calavia, D., Lopez-Yoldi, M., Martinez, J.A., Gonzalez-Navarro, C.J. and Vizmanos, J.L (2018) 'Borago officinalis seed oil (BSO), a natural source of omega-6 fatty acids, attenuates fat accumulation by activating peroxisomal beta-oxidation both in C. elegans and in diet-induced obese rats', Food & Function, 9(8), pp. 4340-4351. doi:10.1039/c8fo00423d Preclinical
https://doi.org/10.1039/c8fo00423d - Moliner, C., Casedas, G., Barros, L., Finimundy, T.C., Gomez-Rincon, C. and Lopez, V (2022) 'Neuroprotective Profile of Edible Flowers of Borage (Borago officinalis L.) in Two Different Models: Caenorhabditis elegans and Neuro-2a Cells', Antioxidants, 11(7), pp. 1244. doi:10.3390/antiox11071244 Preclinical
https://doi.org/10.3390/antiox11071244 - Samy, M.N., Hamed, A.N.E., Sugimoto, S., Otsuka, H., Kamel, M.S. and Matsunami, K (2015) 'Officinalioside, a new lignan glucoside from Borago officinalis L', Natural Product Research, 30(8), pp. 967-972. doi:10.1080/14786419.2015.1088540 Preclinical
https://doi.org/10.1080/14786419.2015.1088540 - Yue, Y., Jin, F. and Yue, X (2021) 'The effect of Borago officinalis on the signaling pathway of the NLRP3 inflammasome complex, TLR4 and some inflammatory cytokines in type II diabetic patients with acute respiratory distress syndrome', Cellular and Molecular Biology, 67(3), pp. 178-183. doi:10.14715/cmb/2021.67.3.28 Clinical study
https://doi.org/10.14715/cmb/2021.67.3.28 - Fernandes, L., Pereira, J.A., Saraiva, J.A., Ramalhosa, E. and Casal, S (2019) 'Phytochemical characterization of Borago officinalis L. and Centaurea cyanus L. during flower development', Food Research International, 123, pp. 771-778. doi:10.1016/j.foodres.2019.05.014 Preclinical
https://doi.org/10.1016/j.foodres.2019.05.014 - European Medicines Agency (HMPC) (2021) 'Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs), including recommendations regarding contamination of herbal medicinal products with PAs, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf - Kapoor, R. and Huang, Y.S (2006) 'Gamma linolenic acid: an antiinflammatory omega-6 fatty acid', 7(6), pp. 531--534. doi:10.2174/138920106779116874 Traditional / reference
https://doi.org/10.2174/138920106779116874 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Negroni, M.S., Marengo, A., Caruso, D., et al (2019) 'A case report of accidental intoxication following ingestion of foxglove confused with borage: high digoxinemia without major complications', Case Reports in Cardiology, 2019, pp. 9707428. doi:10.1155/2019/9707428 Clinical study
https://doi.org/10.1155/2019/9707428 - Iraci, F. and Herdeg, C. and Holzwarth, M. and Storz, M.A (2023) 'Of mixed vegetables and cardiac arrhythmias - Digitalis purpurea confused with Borago officinalis: a case series of accidental digitoxin intoxications', Journal of Cardiology Cases, 28(2), pp. 86-90. doi:10.1016/j.jccase.2023.04.007 Clinical study
https://doi.org/10.1016/j.jccase.2023.04.007
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.